These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 23615394)

  • 61. The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Zhang Y; Miao H; Xie W; Jiang S; Song Z; Huang G; Fan W; Wang Y; Li J; Chen Y
    Eur Radiol; 2021 Jan; 31(1):232-243. PubMed ID: 32728770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
    Georgiades CS; Hong K; D'Angelo M; Geschwind JF
    J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus.
    Hu HT; Luo JP; Li HL; Guo CY; Yao QJ; Geng X; Jiang L
    Oncotarget; 2017 Apr; 8(17):29258-29268. PubMed ID: 28418927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Successful Surgical Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus after Favorable Response to Irradiation and Transcatheter Arterial Chemoembolization].
    Miyahara Y; Takeuchi D; Okabe S; Yoshimura K; Kaneko T; Miura S; Kamiya J; Ashizawa Y; Ogata A
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1842-4. PubMed ID: 26805191
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses.
    Rognoni C; Ciani O; Sommariva S; Facciorusso A; Tarricone R; Bhoori S; Mazzaferro V
    Oncotarget; 2016 Nov; 7(44):72343-72355. PubMed ID: 27579537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang Y; Wu JL; Li LQ
    Ann Hepatol; 2022; 27(1):100552. PubMed ID: 34614432
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
    Liu PH; Huo TI; Miksad RA
    Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
    Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
    Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
    Hata M; Tokuuye K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Ohara K; Matsuzaki Y; Tanaka N; Akine Y
    Cancer; 2005 Aug; 104(4):794-801. PubMed ID: 15981284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A case of multiple hepatocellular carcinoma with rapidly progressing bilateral portal vein tumor thrombosis--a complete remission achieved with dual treatment of reductive surgery plus percutaneous isolated hepatic perfusion].
    Tsuchida S; Fukumoto T; Tominaga M; Iwasaki T; Kusunoki N; Sugimoto T; Kido M; Takebe A; Tanaka M; Hisoka K; Ku Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1818-20. PubMed ID: 16315951
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [A case report of unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus responding to DSM-TACE (degradable starch microspheres-transcatheter arterial chemoembolization)].
    Kirihara M; Nagashima M; Higuchi K; Tahira H; Tajima M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2705-7. PubMed ID: 21224686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.
    Cheng S; Yang J; Shen F; Zhou W; Wang Y; Cong W; Yang GS; Cheng H; Hu H; Gao C; Guo J; Li A; Meng Y; Jiang X; Yang Y; Qian G; Luo M; Hu B; Man X; Zhang B; Su C; Zhou F; Li N; Shi J; Wang M; Zheng Y; Guo W; Sun J; Wang H; Lau WY; Wu MC
    Oncotarget; 2016 Jun; 7(26):40816-40829. PubMed ID: 27027235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of radioembolization according to tumor morphology and portal vein thrombosis in intermediate-advanced hepatocellular carcinoma.
    Golfieri R; Mosconi C; Cappelli A; Giampalma E; Galaverni MC; Pettinato C; Renzulli M; Monari F; Angelelli B; Pini P; Terzi E; Ascanio S; Garzillo G; Piscaglia F; Bolondi L; Trevisani F
    Future Oncol; 2015; 11(23):3133-42. PubMed ID: 26467398
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
    Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ
    J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
    Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R
    Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Long-term survival of a patient with hepatocellular carcinoma with portal vein tumor thrombus treated with interferon-α and 5-fluorouracil combination therapy].
    Tsuda Y; Kobayashi S; Tomimaru Y; Akita H; Hama N; Wada H; Kawamoto K; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1804-6. PubMed ID: 24393928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey.
    Akarca US; Akhan O; Bilgiç S; Bozkurt MF; Cantaşdemir M; Çermik TF; Çakaloğlu Y; Er Ö; Ilgıt E; Çapa Kaya G; Küçük NÖ; Numan F; Parıldar M; Türkmen C
    Diagn Interv Radiol; 2021 Nov; 27(6):732-739. PubMed ID: 34792027
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
    Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
    J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.
    Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV
    J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis.
    Xue TC; Xie XY; Zhang L; Yin X; Zhang BH; Ren ZG
    BMC Gastroenterol; 2013 Apr; 13():60. PubMed ID: 23566041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.